World of DTC Marketing

SEPTEMBER 7, 2022

In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. Biogen’s failure should be a warning to other pharma companies. They relied so much on a new drug that they tried to market a product with bad science behind it.

Pharma 210

Pharma Food and Drug Administration Marketing Prescription 210

World of DTC Marketing

JUNE 23, 2021

Source: Fierce Pharma If that enthusiasm pans out in the long run, it could mean at least 300,000 patients taking the drug, or $10 billion to $15 billion in peak Aduhelm from U.S. Source: STAT News Our healthcare system can’t continue to support drugs that don’t have good clinical outcomes behind them.

FDA 218

FDA Side effects Physicians Patients 218

World of DTC Marketing

NOVEMBER 3, 2020

According to STAT News “Americans consume an average of 1.5 An #NHLBI-funded study put a price tag on American’s bad eating habits: $50 billion a year in health care costs, attributable to cardiometabolic diseases such as heart disease, stroke and type 2 diabetes. We can’t ignore the poor shape of Americans.

Insurance 190

Insurance Healthcare Healthcare Physicians 190

pharmaphorum

DECEMBER 23, 2022

price tag of $475,000 when it was first launched in 2017 – and it becomes apparent that these may not be desirable treatment options for every patient and in every setting. Add to this the considerable cost of these medications – the first approved CAR-T, Novartis’ Kymriah (tisagenlecleucel), had a U.S.

Side effects 52

Side effects Patients Medical Medicine 52

Healthcare Success

MAY 3, 2021

But quite often, the audience is bombarded with retail sales pitches—tons of them—for the likes of AARP, pharma brands, Medicare Advantage, hearing aids, wellness devices, retirement communities, life insurance, cosmetics and many others. They have less concern about the straight-up price tag. Simplicity is good.

Distribution 90

Distribution Marketing Healthcare Healthcare 90

PM360

APRIL 7, 2023

This option grows more critical as new therapies become available with price tags as high as $3.5 million for the new hemophilia gene therapy. Endpoints News , January 20, 2023. Innovative copay solutions that support existing copay card programs enable manufacturers to address financial barriers of patient access. . “$3.5-Million

Manufacturing 52

Manufacturing Marketing Patients Safety 52